drugset / Trial / NCT01216007

A Pilot Study to Investigate Plasma Bupivacaine Concentrations in Children Receiving Total Intravenous Anaesthesia and Caudal Analgesia

NCT01216007

Phase 1/2 Completed 30 enrolled University of British Columbia
RandomizedParallel-groupSingle-blindDiagnostic

Summary

The objective of this pilot study is to compare plasma \[bupivacaine\] between two groups of paediatric patients under general anaesthesia who will all receive regional caudal anaesthesia with bupivacaine: group 1 will receive TIVA and group 2 will receive a volatile anaesthetic.

Timeline

Start
2010-10
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 200 ug/kg Intravenous
Comparator Propofol Small molecule 400 ug/kg Intravenous
Comparator Sevoflurane Other / unclassified 5 % Inhaled
Comparator Sevoflurane Other / unclassified 8 % Inhaled

Indications

No indication recorded.